Dr. Weeks’ Comment: Today, some five years after everyone’s lives were changed by Covid 19 as well as by the pharmaceutical shots the worldwide population was encouraged to take, many previously healthy people are faced with serious debilitation due to either long Covid (driven by persistent spike protein toxicity) or they are tormented by what has been termed Long post-COVID vaccination syndrome (LPCVS). Are you suffering long COVID or are you suffering a chronic reaction to what, scientifically speaking, is not a vaccine but rather a mRNA shot? The answer to that is politically charged, and may be obscured for the next few years, but practically speaking, whether you have one of the other, why not feel better? The remedies for each are the same:
Nattokinase
Bromelain
DrDetox™
Soul
Core
Bend
and consider some may wish to consider a 1 week trial of Nicotine patch – place on back between your shoulders in morning and remove after evening meal.
Here are some articles to study if you are suffering:
https://www.americanthinker.com/articles/2025/06/is_long_covid_actually_vaccine_injury.html
“This is the crux of the problem. Both long COVID and vaccine injury result from an excess of spike protein in the body. Are these two conditions two sides of the same coin? How can one be distinguished from the other?
Let’s follow the science,
The Infectious Disease Society of America (IDSA) estimates that the spike proteins that were generated by COVID-19 vaccines last up to a few weeks, like other proteins made by the body. The immune system quickly identifies, attacks and destroys the spike proteins because it recognizes them as not part of you.”
AND
The Yale LISTEN Study
Harlan Krumholz, MD, a cardiologist at Yale University and Akiko Iwasaki, PhD, professor of immunobiology at Yale University, have launched a post-vaccination study called Listen to Immune, Symptom and Treatment Experiences Now, also known as LISTEN.24 The purpose of the study is to understand Long COVID, post-vaccine adverse events and immune responses by collecting information about symptoms and medical history from participants, including collecting blood and saliva samples.25
Harlan Krumholz, MD said:
It’s my obligation, if I truly am a scientist, to have an open mind and learn if there’s something that can be done. I’m persuaded that there’s something going on” with these side effects.26
AND
https://pmc.ncbi.nlm.nih.gov/articles/PMC9833629/
It is undisputed that anti-SARS-CoV-2 vaccines can have side effects. Long post-COVID vaccination syndrome (LPCVS) is one of them and is often neglected. It persists 11 months after the third mRNA-1273 (Moderna) vaccine dose has not been reported. Our patient is a 39-year-old male with a largely uneventful previous history who developed severe adverse reactions immediately after the third dose of the mRNA-1273 (Moderna) vaccine. In addition to brief fever, headache, flickering eyes, skin rashes, tiredness, disorientation, dizziness (brain fog), tiredness, impaired thinking and concentration, and emotional disorders occurred as a result. Cerebral MRI showed non-specific white matter lesions in a frontotemporal distribution. Some of the immune parameters were deflected. Non-steroidal anti-inflammatory drugs, antihistamines, sartans, and statins have occasionally provided temporary relief. In conclusion, LPCVS is a definite complication of anti-SARS-CoV-2 vaccinations and can severely impact the quality of life and lead to disability. Despite extensive work-up, a clear cause for the long-term neuro-cognitive deficits cannot be identified. Symptomatic treatment can provide some relief. Patients with LPCVS should be taken seriously and treated appropriately.
AND
https://pmc.ncbi.nlm.nih.gov/articles/PMC10663976/
The spike protein of SARS-CoV-2 has been found to exhibit pathogenic characteristics and be a possible cause of post-acute sequelae after SARS-CoV-2 infection or COVID-19 vaccination. COVID-19 vaccines utilize a modified, stabilized prefusion spike protein that may share similar toxic effects with its viral counterpart. The aim of this study is to investigate possible mechanisms of harm to biological systems from SARS-CoV-2 spike protein and vaccine-encoded spike protein and to propose possible mitigation strategies. We searched PubMed, Google Scholar, and ‘grey literature’ to find studies that (1) investigated the effects of the spike protein on biological systems, (2) helped differentiate between viral and vaccine-generated spike proteins, and (3) identified possible spike protein detoxification protocols and compounds that had signals of benefit and acceptable safety profiles. We found abundant evidence that SARS-CoV-2 spike protein may cause damage in the cardiovascular, hematological, neurological, respiratory, gastrointestinal, and immunological systems. Viral and vaccine-encoded spike proteins have been shown to play a direct role in cardiovascular and thrombotic injuries from both SARS-CoV-2 and vaccination. Detection of spike protein for at least 6-15 months after vaccination and infection in those with post-acute sequelae indicates spike protein as a possible primary contributing factor to long COVID. We rationalized that these findings give support to the potential benefit of spike protein detoxification protocols in those with long-term post-infection and/or vaccine-induced complications. We propose a base spike detoxification protocol, composed of oral nattokinase, bromelain, and curcumin. This approach holds immense promise as a base of clinical care, upon which additional therapeutic agents are applied with the goal of aiding in the resolution of post-acute sequelae after SARS-CoV-2 infection and COVID-19 vaccination. Large-scale, prospective, randomized, double-blind, placebo-controlled trials are warranted in order to determine the relative risks and benefits of the base spike detoxification protocol.
AND
https://pmc.ncbi.nlm.nih.gov/articles/PMC9845100/
Following a SARS-CoV-2 infection, many individuals suffer from post-COVID-19 syndrome. It makes them unable to proceed with common everyday activities due to weakness, memory lapses, pain, dyspnea and other unspecific physical complaints. Several investigators could demonstrate that the SARS-CoV-2 related spike glycoprotein (SGP) attaches not only to ACE-2 receptors but also shows DNA sections highly affine to nicotinic acetylcholine receptors (nAChRs). The nAChR is the principal structure of cholinergic neuromodulation and is responsible for coordinated neuronal network interaction. Non-intrinsic viral nAChR attachment compromises integrative interneuronal communication substantially. This explains the cognitive, neuromuscular and mood impairment, as well as the vegetative symptoms, characterizing post-COVID-19 syndrome. The agonist ligand nicotine shows an up to 30-fold higher affinity to nACHRs than acetylcholine (ACh). We therefore hypothesize that this molecule could displace the virus from nAChR attachment and pave the way for unimpaired cholinergic signal transmission. Treating several individuals suffering from post-COVID-19 syndrome with a nicotine patch application, we witnessed improvements ranging from immediate and substantial to complete remission in a matter of days.
AND
https://www.preprints.org/manuscript/202506.0831/v1
COVID‐19 Vaccination and Autoimmune Disorders: A Scoping Review
June 9 2025
Background: Upon the global COVID-19 vaccination campaign, unprecedented in the history of public health, concerns have emerged regarding potential associations between vaccination and autoimmune disorders. Historical research has long identified mechanisms by which vaccines might trigger or unmask autoimmune processes. However, systematic synthesis of evidence concerning COVID-19 vaccines and autoimmunity remains limited. Objective: To review the literature on associations between COVID-19 vaccination and autoimmunity, focusing on six conditions: Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes mellitus.Methods: Following a published protocol, we conducted a scoping review of studies retrieved from PubMed and the WHO COVID-19 database. Inclusion criteria required empirically verifiable clinical manifestations of autoimmune disease following COVID-19 vaccination.Results: Across 109 included studies, relapses or flares in patients with autoimmune disorders were reported in nearly 60% of studies, while about one-quarter described new-onset autoimmune disorders in persons without prior autoimmunity. Several mechanisms of action linking COVID-19 vaccination and autoimmune disorders were identified such as autoimmune inflammatory syndrome induced by adjuvants, molecular mimicry, bystander immune activation, and interactions with immunosuppressive and disease modifying therapies. Serious adverse events, though less common than mild or moderate ones, were also documented. Vaccine efficacy was claimed but empirical support was often lacking.
Conclusions: This review highlights the substantial patterns of reported associations of autoimmune disorders following COVID-19 vaccination, in patients with and without prior autoimmunity. The benefits of vaccination are claimed but evidence for them is lacking. A proper evaluation of risks and benefits is needed to support vaccination recommendations given the reported associations between it and autoimmune disorders.
~~~
REMEDIES to CONSIDER
Regarding Long COVID and/or Long post-COVID vaccination syndrome (LPCVS), in either case Dr. Weeks often utilizes some combination of the following agents as foundational to health recovery.
Nattokinase, an enzyme derived from fermented soybeans, has been explored for its potential benefits in managing Long COVID, particularly due to its fibrinolytic properties that may help address microclots associated with the condition. Nattokinase or nattozyme in 100 mg =2000 FU capsules, with typical dosing ranging from one to two capsules daily away from food.
Bromelain is a proteolytic (protein digesting) enzyme derived from pineapples which when taken away from meals had been very helpful for many illnesses: respiratory illnesses like COVID and other inflammatory challenges. The dosage can start with 500-1,000 mg per day away from food.
SOUL is a unique anti-inflammatory organic non-GMO seed mixture which optimizes nutritional status while shutting down inflammation: black cumin seed oil, Chardonnay grape seed, oil and black raspberry seed oil. The dosage can start with one packet first thing in the morning upon arising, and one packet last thing at night immediately before sleep. Best to keep the box of SOUL in the bathroom so you take it at these times.
CORE is a detoxifying blend of organic non-GMO seeds, helping protect the kidney in the liver as they clean house and detoxify the body. Ingredients are black cumin seed oil, cranberry seed oil and milk thistle seed oil. In addition, CORE features cleansing greens including kale, dandelion, wheat grass, aloe vera, spirulina, and chlorophyllin.
BEND is a seed oil blend of curcumin, bioperin, glucosamine, sulfate, pumpkin seed oil, flaxseed, oil, levagen and the fat soluble vitamins K,D, and E which targets joints ligaments and tendons as well as flushes out cellular debris.
DrDetox™ is a tasteless potent blend of clinoptilolite (a zeolite) which is micronized to a size tiny enough to allow penetration of the blood brain barrier so as to totally clean house, not just in the blood, but the lymph as well. Detoxification is really job number one because if you can’t detox, you will never retain optimal health. The standard maintenance dose is 10 drops under the tongue twice a day away from food by 20 minutes.
Nicotine patch
Early in the pandemic, observations suggested that smokers suffered less COVID than non-smokers. The hypothesis is that nicotine interferes with the virus’s ability to bind to nicotinic acetylcholine receptors on your cells thereby preventing infection and subsequent illness. It is well established that nicotine inhibits the spread of SARS-CoV-2 and this has been substantiated by clinical trials demonstrating the efficacy of nicotine patches in hospitalized patients.
More recent research has edified nicotine patches as a helpful treatment for long COVID due to its ability to reduce inflammation while enhancing cognitive function, and autonomic balance in the nervous system in particular the cholinergic anti-inflammatory pathway. The merits of nicotine patch were substantiated by studies in 2024, which demonstrated that nicotine patches can dislodge the virus allowing for a healing of the cellular membrane. Please note, nicotine should never be delivered through inhalation of cigarette smoke, and also, remember nicotine, while highly beneficial, can be addictive. Treatment of nicotine should be individualized to the patient needs, and frequently a pulse on and off protocol is optimal. Nicotine therapy is safest, if supervised by a medical doctor familiar with its pros and cons.